Katharina S. Schmitz

Author

Erasmus MC ORCID

Also Known As

K.S. Schmitz, Katharina S Schmitz, Katharina S. Schmitz, Schmitz, Katharina S.

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Erasmus MC Erasmus University Rotterdam University of Campania "Luigi Vanvitelli"National Institute for Public Health and the Environment University of California San Diego

About

Katharina S. Schmitz is an author at Erasmus MC specializing in vaccination, vaccine development, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	403
2	Immunology	4	4	403
3	Humoral Immunity	3	3	376
4	Immunodominance	3	3	369
5	Epidemiology	1	1	27

Katharina S. Schmitz

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome Daniela Weiskopf, Katharina S. Schmitz, Matthijs P. Raadsen, Science Immunology	2020	988
SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients Daryl Geers, Marc C. Shamier, Susanne Bogers, Science Immunology	2021	583
Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients Corine H. GeurtsvanKessel, Daryl Geers, Katharina S. Schmitz, Science Immunology	2022	432
Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals Luca M. Zaeck, Mart M. Lamers, Babs E. Verstrepen, Nature Medicine Healthy IndividualsImmunologyImmunodominanceImmunotherapeuticsMonkeypox Virus-neutralizing Antibodies	2022	251
Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets Rory D. de Vries, Katharina S. Schmitz, Francesca T. Bovier, Science	2021	216
Phenotype of SARS-CoV-2-specific T-cells in COVID-19 patients with acute respiratory distress syndrome Daniela Weiskopf, Katharina S. Schmitz, Matthijs P. Raadsen, Adaptive Immune SystemImmunologyImmunodominanceCd4 T Cell ResponsesCovid-19	2020	91
Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant Jan‐Stephan Sanders, A. Lianne Messchendorp, Rory D. de Vries, Clinical Infectious Diseases	2022	52
High Immunogenicity to Influenza Vaccination in Crohn’s Disease Patients Treated with Ustekinumab Laura Doornekamp, Rogier Goetgebuer, Katharina S. Schmitz, Vaccines	2020	44
Divergent SARS CoV-2 Omicron-specific T- and B-cell responses in COVID-19 vaccine recipients Corine H. GeurtsvanKessel, Daryl Geers, Katharina S. Schmitz, VaccinationVaccine DevelopmentCovid-19 Vaccine RecipientsMedicineVaccine Target	2021	34
Intranasal fusion inhibitory lipopeptide prevents direct contact SARS-CoV-2 transmission in ferrets Rory D. de Vries, Katharina S. Schmitz, Francesca T. Bovier,	2020	30

Page 1